Financials
- Market Capitalization 1.78 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.15
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.20% | -7.40% | +3.36% | -36.11% | 1.79 B USD | ||
| 2077 | PGEN Precigen, Inc. - Common Stock | 5.11 USD | -0.20% | -6.75% | +6.24% | +174.73% | 1.82 B USD | ||
| 2117 | IMCR Immunocore Holdings plc - American Depositary Shares | 33.60 USD | +0.39% | +1.94% | +17.44% | +0.36% | 1.71 B USD | ||
| 2120 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.75 USD | +3.69% | +18.42% | +36.09% | +158.62% | 1.74 B USD |